{"metadata": {"source": "psychonaut_CSV", "row": 33, "doc_id": "doc_262", "num_chunks": 8, "chunk_id": "262::chunk_0", "document_index": 262, "latency_s": 0.5371984000084922, "prompt_toks": 1419, "completion_toks": 36}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    drug: Hydromorphone\npsychonaut_name: Hydromorphone\npsychonaut_url: https://psychonautwiki.org/wiki/Hydromorphone\n\n\n                    Context: \n                    This chunk provides the basic identification details for Hydromorphone, including its name and psychosocial reference URL, serving as a foundational reference within the comprehensive drug profile document.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 33, "doc_id": "doc_262", "num_chunks": 8, "chunk_id": "262::chunk_1", "document_index": 262, "latency_s": 0.6560406999924453, "prompt_toks": 1731, "completion_toks": 69}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    Infobox: Hydromorphone | Chemical Nomenclature | Common names | Dilaudid, Jurnista, Palladone | Substitutive name | Hydromorphone | Systematic name | (4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one | Class Membership | Psychoactive class | Opioid | Chemical class | Morphinan | Routes of Administration | WARNING: | Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. | See responsible use section | . | ⇣ | Oral | Dosage | Threshold | 0.5 mg | Light | 1 - 2 mg | Common | 2 - 4 mg | Strong | 4 - 8 mg | Heavy | 8 mg + | Duration | Total | 4 - 6 hours | Onset | 5 - 15 minutes | Come up | 1 - 2 hours | Peak | 15 - 20 minutes | Offset | 30 - 60 minutes | After effects | 1 - 12 hours | ⇣ | Insufflated | Dosage | Threshold | 1 mg | Light | 1 - 2 mg | Common | 2 - 4 mg | Strong | 4 - 8 mg | Heavy | 8 mg + | Duration | Total | 4 - 6 hours | Onset | 1 - 5\n\n\n                    Context: \n                    This chunk provides detailed information from the infobox about hydromorphone, including its chemical nomenclature, common names, classification, routes of administration, dosage guidelines, and pharmacokinetics. It serves as a summary reference within the broader webpage, supporting quick identification and understanding of hydromorphone's key properties and usage parameters.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 33, "doc_id": "doc_262", "num_chunks": 8, "chunk_id": "262::chunk_2", "document_index": 262, "latency_s": 0.9613253999996232, "prompt_toks": 1698, "completion_toks": 58}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    After effects | 1 - 12 hours | ⇣ | Insufflated | Dosage | Threshold | 1 mg | Light | 1 - 2 mg | Common | 2 - 4 mg | Strong | 4 - 8 mg | Heavy | 8 mg + | Duration | Total | 4 - 6 hours | Onset | 1 - 5 minutes | Come up | 5 - 10 minutes | Peak | 30 - 60 minutes | Offset | 15 - 30 minutes | After effects | 1 - 12 hours | ⇣ | Intravenous | Dosage | Threshold | 1 mg | Light | 1 - 2 mg | Common | 2 - 4 mg | Strong | 4 - 6 mg | Heavy | 6 mg + | Duration | Total | 3 - 4 hours | Onset | 4 - 5 minutes | Come up | 10 - 20 minutes | Peak | 30 - 90 minutes | Offset | 1 - 2 hours | After effects | 1 - 2 | hours | DISCLAIMER | : | PW's | dosage | information is gathered from users and | resources | for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. | Interactions | MAOIs | Nitrous | PCP | Stimulants | Alcohol | Benzodiazepines | DXM | GHB | GBL | Ketamine | MXE | Tramadol | Grapefruit\n\n\n                    Context: \n                    This chunk provides detailed dosage, onset, peak, and duration timelines for insufflation and intravenous administration of hydromorphone, including after effects duration. It is essential for understanding safe and effective use, complementing the broader pharmacological and physical effect sections of the full document.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 33, "doc_id": "doc_262", "num_chunks": 8, "chunk_id": "262::chunk_3", "document_index": 262, "latency_s": 0.9175383999972837, "prompt_toks": 1558, "completion_toks": 60}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    Summary: \nContents: \nChemistry: \nPharmacology: \nSubjective effects: \nToxicity and harm potential: \nLegal status: \nSee also: \nExternal links: \nReferences: \nPhysical effects: - Sedation Physical euphoria - In comparison to other opioids, this particular substance can be considered similar in its physical euphoria when compared with that of morphine or diacetylmorphine (heroin) and more intense when compared to kratom and hydrocodone . The sensation itself can be described as feelings of intense physical comfort, warmth, love and bliss. Constipation Cough suppression Decreased libido Difficulty urinating Itchiness Nausea Pain relief Pupil constriction Respiratory depression - This can lead to an increased risk in overdose at high doses. Skin flushing Appetite suppression Orgasm suppression\n- Sedation\n\n\n                    Context: \n                    This chunk provides an overview of the physical effects associated with hydromorphone, including sedation, euphoria, and common opioid side effects such as constipation, nausea, and respiratory depression, making it essential for understanding the drug's pharmacological profile and potential risks discussed throughout the full document.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 33, "doc_id": "doc_262", "num_chunks": 8, "chunk_id": "262::chunk_4", "document_index": 262, "latency_s": 0.6073257999960333, "prompt_toks": 1532, "completion_toks": 69}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - Sedation\n- Physical euphoria - In comparison to other opioids, this particular substance can be considered similar in its physical euphoria when compared with that of morphine or diacetylmorphine (heroin) and more intense when compared to kratom and hydrocodone . The sensation itself can be described as feelings of intense physical comfort, warmth, love and bliss.\n- Constipation\n- Cough suppression\n- Decreased libido\n- Difficulty urinating\n- Itchiness\n- Nausea\n- Pain relief\n- Pupil constriction\n- Respiratory depression - This can lead to an increased risk in overdose at high doses.\n- Skin flushing\n- Appetite suppression\n- Orgasm suppression\n\n\n                    Context: \n                    This section details the physical effects and contraindications associated with hydromorphone, including sedation, euphoria, respiratory depression, and side effects like constipation and pupil constriction. It is part of the broader overview of hydromorphone's pharmacology, physical effects, and potential risks documented in the full webpage.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 33, "doc_id": "doc_262", "num_chunks": 8, "chunk_id": "262::chunk_5", "document_index": 262, "latency_s": 0.8402017999906093, "prompt_toks": 1520, "completion_toks": 72}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - Nausea\n- Pain relief\n- Pupil constriction\n- Respiratory depression - This can lead to an increased risk in overdose at high doses.\n- Skin flushing\n- Appetite suppression\n- Orgasm suppression\nCognitive effects: - Cognitive euphoria - In comparison to other opioids, this particular substance can be considered similar in its cognitive euphoria when compared with that of morphine or diacetylmorphine (heroin) and more intense when compared to kratom and hydrocodone . The sensation itself can be described as powerful and overwhelming feelings of emotional bliss, contentment, and happiness. Anxiety suppression Compulsive redosing Dream potentiation\n\n\n                    Context: \n                    This chunk summarizes key physical and cognitive effects of hydromorphone, including nausea, pain relief, pupil constriction, respiratory depression, skin flushing, appetite and orgasm suppression, and cognitive euphoria with emotional bliss. It provides essential information on the drug's side effects, relevant for understanding its potency and risk profile within the full pharmacological and safety overview.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 33, "doc_id": "doc_262", "num_chunks": 8, "chunk_id": "262::chunk_6", "document_index": 262, "latency_s": 0.7291782999964198, "prompt_toks": 1585, "completion_toks": 90}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - Cognitive euphoria - In comparison to other opioids, this particular substance can be considered similar in its cognitive euphoria when compared with that of morphine or diacetylmorphine (heroin) and more intense when compared to kratom and hydrocodone . The sensation itself can be described as powerful and overwhelming feelings of emotional bliss, contentment, and happiness.\n- Anxiety suppression\n- Compulsive redosing\n- Dream potentiation\nHistory and culture: \nLiterature: \nVisual effects: - Hallucinatory states Internal hallucination - One may experience a state of semi-consciousness and hypnagogia during heavy dosage nodding which results in dream-like states and up to level 3 imagery . This is often accompanied by ill-defined geometry .\n- Internal hallucination - One may experience a state of semi-consciousness and hypnagogia during heavy dosage nodding which results in dream-like states and up to level 3 imagery . This is often accompanied by ill-defined geometry .\n\n\n                    Context: \n                    This excerpt discusses the subjective cognitive effects and visual hallucinations associated with hydromorphone use, highlighting its capacity to induce intense feelings of euphoria, emotional bliss, and dream-like states. It is part of the broader section on physical and sensory effects, providing details on mental and perceptual experiences that may occur during intoxication. This information is relevant for understanding hydromorphone's psychoactive profile and potential impact on cognition and perception.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 33, "doc_id": "doc_262", "num_chunks": 8, "chunk_id": "262::chunk_7", "document_index": 262, "latency_s": 0.944359799992526, "prompt_toks": 1438, "completion_toks": 69}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    Auditory effects: \nMulti-sensory effects: \nTranspersonal effects: \nDisconnective effects: \nAfter effects: \nReagent results: \nPreparation methods: \nResearch: \nExamples: \nLegal issues: \nParadoxical effects: \nOther:\n\n\n                    Context: \n                    This section lists various experiential and procedural topics related to Hydromorphone, including effects on auditory perception, multi-sensory experiences, transpersonal and disconnective states, after effects, and aspects of research, legality, and preparation methods, providing a comprehensive overview of its subjective and practical considerations within the full psychonautical profile.\n                "}
